Project Grant R01CA304407
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $664K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
College Park, MD 20742, USA
Similar Awards
- The National Cancer Institute awarded the University of Maryland, College Park $698,466 on September 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to develop a topical ethanol gel formulation for treating low-grade cervical dysplasia in safety net settings. The project addresses cervical cancer burden in underserved regions where access to preventive care, screening, and dysplasia treatment remains limited. Current standard treatment for high-grade...
- The National Cancer Institute awarded Northeastern University $1,144,692 on September 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) for precision cancer microsurgery using laser ablation-cooling with pulse bursts. The project develops a novel handheld microsurgical device that integrates video cellular-resolution microendoscopy with high-speed pulsed laser ablation to enable rapid visualization and eradication of microscopic tumor deposits at surgical margins...
- The National Cancer Institute awarded Vanderbilt University Medical Center $603,714 on June 18, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop an enhanced visualization and navigation system that improves surgical accuracy during endoscopic treatment of upper tract urothelial carcinoma. Current endoscopic tumor ablation relies on surgeons mentally constructing three-dimensional maps of branched renal anatomy from two-dimensional preoperative imaging, a...
- The National Institute of Biomedical Imaging and Bioengineering awarded Rice University $182,736 on August 3, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a multi-modal, multi-depth, high-resolution micro-endoscope (M3D-HRME) for early cancer detection. The project pursues feasibility studies to create optical micro-endoscopic devices capable of detecting early-stage cancer by combining advances in...
- The National Cancer Institute awarded the University of Maryland, College Park $369,075 on June 1, 2026, under the Cancer Biology Research program (CFDA 93.396) to develop computational methods for reconstructing transposable element activity in cancer genomes using long-read sequencing and local assembly approaches. The project addresses a fundamental gap in cancer genomics: somatic transposition events—insertions where DNA sequences jump or copy themselves to new genomic locations—occur in...
- The National Cancer Institute awarded The University of Texas Southwestern Medical Center $623,432 on May 7, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop enhancements to the Cancer Vision Goggle (CVG), a head-mounted fluorescence-guided surgery system designed to reduce positive margin rates in cancer resection. The award funds three core improvements to the CVG platform: transitioning from monocular to stereoscopic vision to enhance tissue contour...
- Federal Project Grant Award Summary Navigation Sciences Inc. received a $225,229 Project Grant award on September 19, 2025, from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) to develop EndonaviSci, an advanced navigation software system designed to improve lung cancer surgical outcomes. The software will address critical clinical challenges in performing segmentectomy—a lung-preserving surgical procedure—by enabling accurate localization...
- The National Institutes of Health National Cancer Institute awarded The Leland Stanford Junior University $395,973 on June 9, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop and validate an augmented reality system that projects volumetric MRI data inside the breast to guide lumpectomy surgery and reduce positive margin rates. The project addresses the clinical problem that approximately half of women undergoing initial lumpectomy for newly diagnosed...
- Federal Grant Award Summary The Medical University of South Carolina received a $388,256 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), effective September 1, 2025 through August 31, 2027. This award supports research investigating the biologic rationale for fallopian tube removal as a preventive intervention against uterine serous carcinoma (USC), a highly aggressive form of uterine cancer responsible for 40% of endometrial...
- Federal Grant Award Summary Illuminant Surgical Inc. received a $1,107,943 Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) awarded on September 12, 2025, with a completion date of August 31, 2027. This Phase II effort focuses on the continued development and validation of Skylight, a mixed-reality navigation platform designed to improve the accuracy and safety of image-guided biopsy procedures. The platform employs advanced...